These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9827982

  • 1. Rhinocerebral mucormycosis following donor leukocyte infusion: successful treatment with liposomal amphotericin B and surgical debridement.
    Peñalver FJ, Romero R, Forés R, Cabrera R, Díez-Martin JL, Regidor C, Fernández MN.
    Bone Marrow Transplant; 1998 Oct; 22(8):817-8. PubMed ID: 9827982
    [Abstract] [Full Text] [Related]

  • 2. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 3. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Salonen JH.
    Acta Biomed; 2006 Mar; 77 Suppl 2():28-31. PubMed ID: 16918065
    [Abstract] [Full Text] [Related]

  • 4. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA.
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [Abstract] [Full Text] [Related]

  • 5. Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.
    Grigg A, Szer J.
    Bone Marrow Transplant; 1996 Sep; 18(3):647-8. PubMed ID: 8879633
    [Abstract] [Full Text] [Related]

  • 6. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S, Yabe H, Kato S, Imoto S, Maruta A, Yoshida T, Gondo H, Morishima Y, Kodera Y.
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [Abstract] [Full Text] [Related]

  • 7. Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CML.
    Rahman SL, Mahendra P, Nacheva E, Sinclair P, Arno J, Marcus RE.
    Bone Marrow Transplant; 1998 May; 21(9):955-6. PubMed ID: 9613792
    [Abstract] [Full Text] [Related]

  • 8. Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation.
    Leleu X, Sendid B, Fruit J, Sarre H, Wattel E, Rose C, Bauters F, Facon T, Jouet J.
    Bone Marrow Transplant; 1999 Aug; 24(4):417-20. PubMed ID: 10467332
    [Abstract] [Full Text] [Related]

  • 9. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W.
    J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
    [Abstract] [Full Text] [Related]

  • 10. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Maeda A, Yamamoto K, Kotone Y, Yamashita K, Yoshinaga N, Hirata H, Asagoe K, Nohgawa M, Takahashi A, Ohno H, Tashima M, Sasada M.
    Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C, Steegmann JL, Granda A, de la Cámara R, Figuera A, Arranz R, Gómez-García de Soria V, Alegre A, Fernández-Rañada JM.
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [Abstract] [Full Text] [Related]

  • 12. [Donor leukocyte transfusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Itoh T, Hatta Y, Miyajima T, Simojima H, Sawada U, Horie T.
    Rinsho Ketsueki; 1998 Jun; 39(6):409-15. PubMed ID: 9695667
    [Abstract] [Full Text] [Related]

  • 13. Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B.
    Alobid I, Bernal M, Calvo C, Vilaseca I, Berenguer J, Alós L.
    Am J Rhinol; 2001 Jun; 15(5):327-31. PubMed ID: 11732820
    [Abstract] [Full Text] [Related]

  • 14. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, Galinsky I, Parekkedon B, Ritz J, Antin JH, Stone RM, Soiffer RJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5065-71. PubMed ID: 15297408
    [Abstract] [Full Text] [Related]

  • 15. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3(+) and CD4(+) lymphocytes.
    Vela-Ojeda J, García-Ruiz Esparza MA, Reyes-Maldonado E, Jiménez-Zamudio L, Moreno-Lafont M, García-Latorre E, Ramírez-Sanjuan E, Montiel-Cervantes L, Tripp-Villanueva F, García-León LD, Ayala-Sánchez M, Rosas-Cabral A, Aviña-Zubieta JA, Galindo-Rodríguez G, Vadillo-Buenfil M, Salazar-Exaire D.
    Ann Hematol; 2004 May 01; 83(5):295-301. PubMed ID: 15060749
    [Abstract] [Full Text] [Related]

  • 16. Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?
    Handzel O, Landau Z, Halperin D.
    Rhinology; 2003 Sep 01; 41(3):184-6. PubMed ID: 14579660
    [Abstract] [Full Text] [Related]

  • 17. [Rhinocerebral mucormycosis. Apropos of a case].
    Escalante Avila A, Medina Gómez J, de Juan Ivars C, Portell Soriano M, Fernández Vega M.
    Acta Otorrinolaringol Esp; 1989 Sep 01; 40(1):51-2. PubMed ID: 2629928
    [Abstract] [Full Text] [Related]

  • 18. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K, Wano Y, Yamamoto S, Ikebata Y, Iwasaki H, Tsutani H, Naiki H, Ueda T.
    Anticancer Res; 1999 Sep 01; 19(6C):5631-4. PubMed ID: 10697631
    [Abstract] [Full Text] [Related]

  • 19. Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management.
    Munir N, Jones NS.
    J Laryngol Otol; 2007 Feb 01; 121(2):192-5. PubMed ID: 17134533
    [Abstract] [Full Text] [Related]

  • 20. Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality.
    Jung SH, Kim SW, Park CS, Song CE, Cho JH, Lee JH, Kim NS, Kang JM.
    Auris Nasus Larynx; 2009 Jun 01; 36(3):274-9. PubMed ID: 18786790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.